RSSAll Entries in the "Dangerous Drugs" Category

post thumbnail

Benicar (olmesartan): Ongoing Safety Review

FDA evaluating data in which type 2 diabetes patients taking Benicar had a higher rate of death from cardiovascular cause compared to placebo. FDA has not concluded that Benicar increases the risk of death.

post thumbnail

Vitamin D Supplement Products: Medication Use Error

Some liquid Vitamin D supplement products are sold with droppers that could allow parents to accidentally give harmful amounts of Vitamin D to their infant.

post thumbnail

McNeil Consumer Healthcare Over-The-Counter Products: Recall

UPDATED 06/17/2010. Recall expanded to include product lots of Benadryl Allergy Ultratab Tablets and Extra Strength Tylenol Rapid Release Gels.

post thumbnail

Magic Power Coffee: Undeclared Drug Ingredient

Product marketed as a dietary supplement for sexual enhancement contains the drug ingredient hydroxythiohomosildenafil, a chemical that may interact with prescription nitrates, and cause dangerously low blood pressure.

post thumbnail

Mylotarg (gemtuzumab ozogamicin): Market Withdrawal

Drug failed to demonstrate clinical benefit to patients enrolled in trials.

post thumbnail

Tamiflu: Counterfeit Product Sold on Internet

Potentially harmful product represented as “Generic Tamiflu”- tests revealed product does not contain oseltamivir, but cloxacillin, an antibiotic.

post thumbnail

Hospira Brand Liposyn and Propofol: Recall

Injectable products may contain particulate matter.

post thumbnail

Orlistat (marketed as Alli and Xenical): Labeling Change

Revised labeling to include cases of severe liver injury.

post thumbnail

Hylenex recombinant (hyaluronidase human injection): Recall

Voluntary recall of all manufactured lots has been initiated as a precautionary measure due to instances of particulate matter observed in a limited number of vials during routine stability testing.

post thumbnail

Arrow Brand Medicated Oil and Embrocation: Consumer Warning, Product Considered Toxic

Product contains substances which are poisonous when ingested or applied to large areas of the body.

post thumbnail

Intravenous Medications Manufactured by Claris: Recall due to contamination of products

Products sold under the Claris, Sagent Pharmaceuticals, Pfizer, and West-Ward Pharmaceuticals labels. Reports of floating matter in intravenous bags of metronidazole and ondansetron. Foreign matter should not be present in a sterile injectable product.

  • Calendar
    September 2010
    M T W T F S S
    « Aug    
     12345
    6789101112
    13141516171819
    20212223242526
    27282930